NEW YORK, September 30, 2016 /PRNewswire/ --
The medical devices market is very diverse, with devices that
focus on various medical needs and procedures. On area where
innovation is expected is the cardiac medical devices market. A
research report by Absolut Reports indicates what the issues are in
the market today, and its potential growth. The cardiac medical
devices market in the US is estimated to grow at a CAGR of 1.82%
during the period 2016-2020. . BioSig Technologies Inc.
(OTCQB: BSGM), Medtronic PLC (NYSE: MDT), C R Bard
Inc. (NYSE: BCR), Cardinal Health Inc. (NYSE: CAH),
Edwards Lifesciences Corp. (NYSE: EW).
Two heart conditions atrial fibrillation (AF) and ventricular
tachycardia (VT), characterized by irregular heartbeat, are quite
common. This condition occurs when the heart is no longer able to
properly function, a malfunction in the electrical impulses of the
heart occurs. This could, in worth case scenarios lead to sudden
cardiac arrest or heart failure. The Center for Disease Control has
estimated that about 6 million people were diagnosed with AF in
2015, and it is most common in older populations, among people 60
years or above.
Medical device companies have always considered cardiology as
one of the most important sectors. New innovations and developments
have made heart rate measurements more accurate and analytical.
Advancements are still being made in this sector and could lead to
much bigger findings. BioSig Technologies Inc.
(OTCQB: BSGM) for example is a development-stage medical
device company which is focused on a technology platform to manage
noises and artifacts from cardiac recordings during
electrophysiology studies and ablation. The platform is the Precise
Uninterrupted Real-time evaluation of Electrograms (PURE)
electro-pneumatic (EP) System.
The PURE EP system is a novel platform designed to obtain and
display important clinical data during electrophysiology
procedures. BioSig Technologies Inc. (
BSGM) claims the system to be precise, uninterrupted,
capable of real-time evaluations of Electrograms. The feature of
the PURE EP System that are designed to improve upon today's
devices used for similar procedures by detecting and displaying
high fidelity cardiac signals, which the company claims are not
detectable by other recording devices.
The technology used in the PURE EP has been discussed in studies
from Texas Cardiac Arrhythmia Institute, Mayo Clinic, Mount Sinai and UCLA with data
presented at world-renowned conferences. The data positively
indicates that the technology has the potential to shorten
procedure time as well as eliminating, or the very least reducing
the need for repeated procedures, which are frequent with devices
used today. BioSig Technologies Inc. (BSGM)
plans to apply via a 510(k) pathway with the Food and Drug
Administration in the first half of 2017.
Large cap companies like Medtronic PLC (NYSE: MDT) is a
medical technology and services company that manufactures and
markets its medical devices and technologies to hospitals,
physicians, clinicians and patients in approximately 160 countries.
The company has a cardiac and vascular segment includes products
for cardiac rhythm and heart failure monitoring. The company's
resynchronization therapy is a proven treatment for selected heart
failure patients with a wide QRS. When used in combination with
optimal medical therapy, cardiac resynchronization therapy improves
symptoms and extends survival.
C R Bard Inc. (NYSE: BCR) is a designing,
manufacturing, packaging, distribution and sale of medical,
surgical, diagnostic and patient care devices. The company has
a cardiac monitoring division, which provides Temporary Pacing
Electrode Catheters. The catheters designed to reduces the need for
repositioning, saving physician time and minimizing patient
discomfort.
Cardinal Health Inc. (NYSE: CAH) a healthcare
services and products company. For evaluating cardiovascular
disease, the company is known for Single-photon emission computed
tomography (SPECT) which is a nuclear medicine tomographic imaging
technique using gamma rays. Cardiac SPECT can identify areas of the
heart which do not receive adequate blood flow during stress,
called ischemia, as well as find areas of irreversibly damaged
heart, or scar. It is considered to be a very important tool for
detecting and evaluating cardiovascular disease.
Edwards Lifesciences Corp. (NYSE: EW) is focused
on developing technologies that treat structural heart disease. The
Company is known for their heart valve systems and repair products
used to replace or repair a patient's diseased or defective heart
valve. The company's cardio medical devices are hemodynamic
monitoring systems used to measure a patient's cardiovascular
function in the hospital setting.
Subscribe Now! Watch us report from NYSE
https://www.youtube.com/FinancialBuzzMedia
For "The Latest Buzz in Financial News", SIGN UP & Visit:
http://www.FinancialBuzz.com
Follow us on Twitter for real time Financial News Updates:
https://twitter.com/financialbuzz
Follow and talk to us on Instagram:
https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds:
https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web
portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth
broadcasts on Stock News, Market Analysis and Company Interviews. A
pioneer in the financially driven digital space, video production
and integration of social media, FinancialBuzz.com creates 100%
unique original content. FinancialBuzz.com also provides financial
news PR branding, marketing and advertising for third parties for
disseminating news and original content through our unique media
platform that includes Newswire Delivery, Digital Advertising,
Social Media Relations, Video Production, Broadcasting, and
Financial Publications.
Please Note: FinancialBuzz.com is not a financial advisory or
advisor, investment advisor or broker-dealer and do not undertake
any activities that would require such registration. The
information provided on http://www.FinancialBuzz.com (the "Site")
is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content),
FinancialBuzz.com, a financial news media and marketing firm enters
into service agreements with the companies which are the subject to
the articles posted on the Site for advertising such companies.
Financialbuzz.com has been compensated twelve thousand dollars for financial news pr
services by a non-affiliated third party for biosig technologies
inc. We are not an independent news media provider and therefore do
not represent or warrant that the information posted on the Site is
accurate, unbiased or complete. FinancialBuzz.com receives fees for
producing and presenting high quality and sophisticated content on
this site along with other financial news pr media services. Our
fees may be either a flat cash sum or negotiated number of
securities of the companies featured on this site, or a combination
thereof. The securities are commonly paid in segments, of
which a portion is received upon engagement and the balance is paid
on or near the conclusion of the engagement. FinancialBuzz.com does
not undertake to update any of the information on the Site or
continue to post information about any companies the information
contained herein is not intended to be used as the basis for
investment decisions and should not be considered as investment
advice or a recommendation. The information contained herein is not
an offer or solicitation to buy, hold or sell any security.
FinancialBuzz.com, members and affiliates are not responsible
for any gains or losses that result from the opinions expressed on
the Site, company profiles, quotations or in other materials or
presentations that it publishes electronically or in print.
Investors accept full responsibility for any and all of their
investment decisions based on their own independent research and
evaluation of their own investment goals, risk tolerance, and
financial condition. FinancialBuzz.com. By accessing this website
and any pages thereof, you agree to be bound by the Terms of Use
and Privacy Policy, as may be amended from time to time. None of
the content issued by FinancialBuzz.com constitutes a
recommendation for any investor to purchase, hold or sell any
particular security, pursue a particular investment strategy or
that any security is suitable for any investor. This publication is
provided by FinancialBuzz.com. Each investor is solely responsible
for determining whether a particular security or investment
strategy is suitable based on their objectives, other securities
holdings, financial situation needs, and tax status. You agree to
consult with your investment advisor, tax and legal consultant
before making any investment decisions. We make no representations
as to the completeness, accuracy or timeless of the material
provided. All materials are subject to change without notice.
Information is obtained from sources believed to be reliable, but
its accuracy and completeness are not guaranteed. For our full
disclaimer, disclosure and Terms of Use. Please visit:
http://www.financialbuzz.com
For further information:
Media Contact: Danny A., info@financialbuzz.com,
+1-877-601-1879
SOURCE FinancialBuzz.com